Recent Updates
Recently added Catalysts
PHG Positive Sentiment

Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Philips has launched the Lumea IPL 9900 Pro, an at-home hair removal device featuring real-time audio guidance. This innovative product aims to enhance user confidence and personalize the hair removal experience. As the leading IPL brand, Philips leverages 25 years of research to ensure effective treatment.

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of innovative audio-guided IPL device
  • Enhances user confidence during hair removal
  • Backed by 25 years of IPL research

Full Press Release Details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, this month launched the Philips Lumea IPL 9900 Pro, transforming at-home hair removal into a personalized and rewarding self-care routine. Philips Lumea IPL 9900 Pro is the first at-home IPL with audio feedback and motion guidance that talks to users2, helping give them greater confidence in effective treatment. As the world’s no. 1 IPL brand3, Philips brings 25 years of IPL research a

Frequently Asked Questions

What is the Philips Lumea IPL 9900 Pro?

It's an at-home hair removal device featuring audio guidance and motion feedback.

How does the audio guidance work?

The device provides real-time audio feedback to enhance user confidence during treatment.

What makes this IPL device unique?

It's the first at-home IPL device with audio feedback, making treatments more personalized.

How long has Philips been in the IPL market?

Philips has over 25 years of research in the IPL field.

ShareAdd on Google
Tags: PHG Viatris Investor Conferences Healthcare Philips IPL hair removal Lumea self-care
Last updated: Sep 8, 2026

Biotech snapshot

Lead asset
CLiRpath Photoablation SystemPhase 3
Peripheral Artery Disease →